ASND - Ascendis Pharma A/S

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts5565
Avg. Estimate-1.07-1.1-4.53-4.53
Low Estimate-1.25-1.32-5.25-5.77
High Estimate-0.75-0.75-3.6-2.2
Year Ago EPS-1.15-1.27-4.51-4.53
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts4465
Avg. Estimate130k130k3.05M2.6M
Low EstimateN/AN/AN/AN/A
High Estimate240k240k12.24M12.24M
Year Ago Sales543.64k531.39k1.87M3.05M
Sales Growth (year/est)-76.10%-75.50%62.80%-14.80%
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-0.88-0.9-0.98-0.94
EPS Actual-1.15-1.27-1.13-1.31
Difference-0.27-0.37-0.15-0.37
Surprise %-30.70%-41.10%-15.30%-39.40%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate-1.07-1.1-4.53-4.53
7 Days Ago-1.07-1.1-4.53-4.53
30 Days Ago-1.02-1.04-4.37-4.49
60 Days Ago-0.92-0.92-3.82-4.06
90 Days Ago-0.91-0.91-3.85-3.93
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesASNDIndustrySectorS&P 500
Current Qtr.7.00%N/AN/A0.43
Next Qtr.13.40%N/AN/A0.47
Current Year-0.40%N/AN/A0.22
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)24.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A